Tril­lion-dol­lar part­ner: Re­cur­sion rais­es $50M from Nvidia, stock sky­rock­ets

Re­cur­sion Phar­ma­ceu­ti­cals raised $50 mil­lion from Nvidia via a PIPE that placed the AI biotech square­ly in­to the in­vestor fer­vor sur­round­ing the tech com­pa­ny.

Re­cur­sion said Wednes­day morn­ing it now plans to work with Nvidia on the soft­ware com­pa­ny’s cloud ser­vice that us­es gen­er­a­tive AI for drug dis­cov­ery. Re­cur­sion brings a mas­sive bio­chem­i­cal dataset through which Nvidia’s drug dis­cov­ery foun­da­tion mod­els can be trained.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER